This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Small Cap Rally
by Sheraz Mian
After lagging the S&P 500 index for most of this year, the small caps appear to have finally taken market leading position.
An Infographic Preview of Q3 Earnings Season
by Ryan McQueeney
For a detailed look at the latest earnings trends, including a peek at how our estimates have changed over time and what we expect in future quarters, check out our new Q3 earnings preview infographic!
What Will Be the Rally's Next Catalyst?
by Sheraz Mian
Don't be fooled by the "correction chatter" that is persistent in the market right now. Sheraz Mian offers three meaningful ways that the earnings picture has improved from the trend in place over the last two years.
Q2 GDP Keeps a 3-Handle, Plus More Data
by Mark Vickery
The third read on GDP, which had previously eked out a positive 3.0%, finished up another tenth of a point to 3.1%.
3 Foolproof Solutions for Options Mistakes
by Kevin Matras
Kevin Matras goes over three common mistakes of options traders and their foolproof solutions.
Fed Signals Re-Think; Durable Goods Orders Up
by Mark Vickery
August Durable Goods Orders were much better than expected: the headline preliminary read of 1.7% nearly doubled the 0.9% expected by analysts.
3 Steps to "Buy What You Know" Success
by Tracey Ryniec
"Buy what you know" is not as simple as it sounds, but Tracey Ryniec has 3 simple steps that will help you uncover great growth opportunities.
The Secret to Finding the Next Big Thing
by David Bartosiak
Trading momentum stocks is all about finding the right markets, and Dave Bartosiak is focused on one that has been scorching hot in the past month. Learn about the "special recipe" he used to find this space and its next breakout stocks.
Bear-Market Fears Emerging?
by Mark Vickery
Between Robert Shiller's warning yesterday, the Fed's tightening plan and news headlines lurking, investors do have plenty of reasons to be cautious ahead.
Best ETF Strategies for a Hawkish Fed
by Sanghamitra Saha
Fed gives indications of unwinding of balance sheet from next month, hints at rate hike and makes these ETF strategies lucrative.
What We Did on Summer Vacation
by Mark Vickery
This summer, marked as usual by lower trading volumes overall, held up remarkably well despite plenty of headwinds.
Investing in the Road Less Traveled
by Kevin Matras
Why options are my favorite way to trade and why you need them in your portfolio now more than ever.
Read This Before Your Next Trade
by Kevin Matras
Bullish or bearish, these must-see tips can help you win on your next trade.
Hurricanes, Earthquakes and Record-High Markets
by Mark Vickery
With Hurricane Maria striking Puerto Rico and two major earthquakes destroying parts of Mexico, markets continue to reach for new record highs.
Four Steps to Mastering Momentum Stocks
by David Bartosiak
Momentum stocks offer the highest reward in the shortest amount of time...but only if you know how to pick the real winners.
Hurricane Troubles, Continued
by Mark Vickery
As Hurricane Maria barrels down on islands in the Caribbean, Trian's Nelson Peltz faces a storm in his bid for a board seat at P&G.
The Power of New Analyst Coverage
by Kevin Matras
Kevin Matras shows why stocks with new analyst coverage are stocks you want to have. Highlighted stocks include LIVN, CLDT, ASML, HEI and ETSY.
S&P 500 Hits 2,500 Mark: How to Trade With ETFs
by Sweta Killa
How to bet on S&P 500 index with ETFs.
Three Reasons to Bet on Small Cap ETFs Now
by Sweta Killa
The impressive gains came mainly on hopes of tax reform, which is expected by the end of the year.
Read This Before Your Next Trade
by Kevin Matras
Bullish or bearish, these must-see tips can help you win on your next trade.
One Little Secret for Big Results
by Kevin Matras
It will make a sizable impact on your life...including your stock portfolio.
The Rally Continues
by Sheraz Mian
There is no compelling reason to lower your exposure to the market.
Should You Keep Your Portfolio Healthy with Biotech ETFs?
by Sanghamitra Saha
Biotech ETFs are riding high on research and developments and FDA approvals.
Market Hits New Record High: Growth ETFs Top
by Sweta Killa
While the rally has been broad-based, growth ETFs are leading the way.
Weekly ETF Roundup: Treasury & Gold Shine, U.S. Equity Mixed
by Sweta Killa
Last week saw increased geopolitical risks and formation of Hurricane Irma.